HR 4404
116th Congress
House
Health
Administrative law and regulatory procedures
Consumer affairs
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)
Mental health
Depression Side Effect Labeling Awareness Act of 2019
Introduced: September 19, 2019
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 20, 2019
Referred to the Subcommittee on Health.
Sep 19, 2019
Referred to the House Committee on Energy and Commerce.
Sep 19, 2019
Introduced in House
Plain-English summary
Depression Side Effect Labeling Awareness Act of 2019
This bill specifies that, if a drug's label indicates an increased risk of suicide or depression, this information must displayed prominently.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2